Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MAPS

EXCLUSIVE: Catalysts To Watch For In The Psychedelic Space

Any biotech investor knows how important catalysts are for the companies in the space. One FDA approval or denial can make or break the price of the stock. In the psychedelic space, catalysts could be even more important, as the industry as a whole is still in its infancy.

Benzinga

How to find eco-friendly routes and EV charging stops in Google Maps

Google lets you prioritize fuel-efficient routes, shows bike and train information for alternatives, helps you find charging stations for your EV, and more. Here's how to save gas (and the environment) and be more eco-friendly when on the go with Google Maps.

Android Central

3 Best Small-Cap Software Stocks to Buy in April

The software industry is expected to grow tremendously in the coming months, thanks to accelerating digitalization and technology dependence amid continuing remote lifestyles. Thus, we think it could be wise to invest now in fundamentally solid small-cap software stocks CSG Systems (CSGS), WM Technology (MAPS), and Benefitfocus (BNFT).

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

P&O workers losing their jobs warned of risk that could wipe out pension pots

Hundreds of P&O Ferries workers laid off last month are in danger of switching their retirement funds into less generous alternatives, financial experts are warning

Daily Mirror

Is The UK Becoming A Global Center For Psychedelic Medicine?

This article by Freddie Earlam was originally published on Microdose and appears here with permission. If the industry-defining research already conducted at UK centers such as Imperial College, King’s college or even Exeter University’s recent Ketamine Research isn’t enough to convince you, then two more crucial factors surely will. Firstly, a new ‘accelerated pathway’ has…

Benzinga

These 3 Psychedelic Stocks Will Benefit When The FDA Green-Lights MDMA (Molly, Ecstasy)

What Happened: According to the Multidisciplinary Association of Psychedelic Studies (MAPS), a non-profit organization, the FDA is close to greenlighting MDMA as a treatment for PTSD. MAPS reported positive results from a phase-3 trial testing the efficacy of MDMA-assisted therapy.

Benzinga

Numinus Administers MDMA To First Volunteer In Clinical Trial Sponsored By MAPS

Numinus Wellness Inc. (OTCQX:NUMIF), announced that clinical trial MAPPUSX has gotten underway with the enrolling and dosing of the first trial volunteer in Canada. MAPPUSX, which stands for "A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD”, is sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS) and organized by…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Top 5 Most Influential Psychedelic Studies

This article was originally published on Psychedelic Spotlight and appears here with permission. While psychedelic studies now number in the thousands since Western research began in the 1950s, we unpack five of the most important in recent years as psychedelics are on the cusp of becoming mainstream medicines. When it…

Benzinga

Can Psychedelics Like MDMA Cure Eating Disorders?

This article was originally published on Psychedelic Spotlight and appears here with permission. Multidisciplinary Association for Psychedelic Studies (MAPS) published a study which found that MDMA-assisted therapy significantly reduced symptoms of eating disorders. Anyone who has ever suffered from an eating disorder, such as anorexia or bulimia, knows that beating…

Benzinga

Apple Maps: 15 essential tips and tricks

These 15 tips and tricks can enhance Apple Maps and make sure you get the most out of it.

Tom’s Guide

Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial

A new company has entered the public psychedelic markets, with an alternative drug-to-market approach. Using Real World Evidence trials, Albert Labs is expecting to legally provide psilocybin to patients in the UK much earlier than companies working with to get FDA approval.

Benzinga

WM Technology, Inc. Appoints Anthony Bay As New Chairman Of Board of Directors

WM Technology, Inc. (NASDAQ: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, announced on Thursday that it had appointed Anthony Bay as the new chairman of the Company's Board of Directors.

Benzinga

Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy

Michael Mullette, a former Moderna (NASDAQ:MNRA) vice president is taking a senior leadership position in the MAPS Public Benefit Corporation, a biotech company in the psychedelics sector. The MAPS PCB is a for-profit company wholly owned by the Multidisciplinary Association for Psychedelic Studies, a nonprofit founded in 1986 to advance patient…

Benzinga

WM Technology Shares Skyrocket, Analyst Says The Stock Looks Attractive

WM Technology, Inc. (NASDAQ: MAPS), a marketplace and technology solutions provider to the cannabis industry, released its e

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

WM Technology Reports Q4 And Full-Year 2021 Financial Results

WM Technology, Inc. (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, announced its financial results late for the fourth quarter ending December 31, 2021.

Benzinga

WM Technology Reports Fourth Quarter And Full Year 2021 Financial Results

WM Technology, Inc. (Nasdaq: MAPS), a leading marketplace and technology solutions provider to the cannabis industry, announced its financial results late Wednesday for the fourth quarter ending December 31, 2021.

Benzinga

Why Broccoli? Cannabis Companies Grapple With Marketing And Advertising Hurdles

This article by Lauren Wilson was originally published on Weedmaps (NASDAQ: MAPS) and appears here with permission.

Benzinga

WM Technology To Hold Q4 Earnings Conference Call

Cannabis-focused tech company WM Technology, Inc. (NASDAQ: MAPS) announced that it will report financial results for its fourth quarter ended December 31, 2021 after market close on Wednesday, February 23, 2022.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Cannabis Analyst Advises Not To Buy WeedMaps Shares Until March

Cantor Fitzgerald has issued a new report on cannabis tech platform WeedMaps (NASDAQ: MAPS), also known as WM Technology Inc.

1 … 7 8 9 10

People

Tom Guide

3,704 stories

Mangeet Kaur BounsMangeet

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.